Supplementary Data from Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma

Authors :: Philip A. Philip
Ramzi M. Mohammad
Vinod Shidham
Steve Kim
Anteneh Tesfaye
Mohammad Najeeb Al-Hallak
Mandana Kamgar
Gregory Dyson
Amit Mahipal
Dirk Daelemans
Jasper E. Neggers
Amro Aboukameel
Irfana Muqbil
Husain Yar Khan
Asfar S. Azmi
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Legends to supplementary Figure

Full Text Access

Tools